ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Neoadjuvant immunotherapy for non-small cell lung cancer: State of the art

Kang, Jin; Zhang, Chao; Zhong, Wen-Zhao*广东省人民医院; 南方医科大学
Cancer Communications2021-4DOI: 10.1002/cac2.12153
62被引10阅读
引用收藏
分享

摘要

Lung cancer mortality has decreased over the past decade and can be partly attributed to advances in targeted therapy and immunotherapy. Immune checkpoint inhibitors (ICIs) have rapidly evolved from investigational drugs to standard of care for the treatment of metastatic non-small cell lung cancer (NSCLC). In particular, antibodies that block inhibitory immune checkpoints, such as programmed cell death protein 1 (PD-1) and programmed cell death 1 ligand 1 (PD-L1), have revolutionized the treatment of advanced NSCLC, when administered alone or in combination with chemotherapy. Immunotherapy is associated with higher response rates, improved overall survival (OS), and increased tolerability compared with conventional cytotoxic chemotherapy. These benefits may increase the utility of immunotherapy and its combinational use with chemotherapy in the neoadjuvant treatment of patients with NSCLC. Early findings from various ongoing clinical trials suggest that neoadjuvant ICIs alone or combined with chemotherapy may significantly reduce systemic recurrence and improve long-term OS or cure rates in resectable NSCLC. Here we further summarize the safety and efficacy of various neoadjuvant treatment regimens including immunotherapy from ongoing clinical trials and elaborate the role of neoadjuvant immunotherapy in patients with resectable NSCLC. In addition, we discuss several unresolved challenges, including the evaluations to assess neoadjuvant immunotherapy response, the role of adjuvant treatment after neoadjuvant immunotherapy, the efficacy of treatment for oncogenic-addicted tumors, and predictive biomarkers. We also provide our perspective on ways to overcome current obstacles and establish neoadjuvant immunotherapy as a standard of care.

学科与关键词

关键词
chemoimmunotherapyclinical trialsimagingimmunotherapyneoadjuvantnon&#8208small cell lung cancerperioperativeradiotherapysurgery
相关
加载中…
  • Adjuvant immunotherapy in early-stage resectable non-small cell lung cancer: A new milestone
    Tang, Wen-Fang; Ye, Hong-Yu; Tang, Xuan; Su, Jian-Wei; Xu, Kang-Mei; Zhong, Wen-Zhao*; Liang, Yi*Frontiers in Oncology, 2023, 13: 1063183.被引 4
  • Induction immune-checkpoint inhibitors for resectable oncogene-mutant NSCLC: A multicenter pooled analysis
    Zhang, Chao; Chen, Hua-Fei; Yan, Shi; Wu, Lin; Yan, Li-Xu; Yan, Xiao-Long; Yue, Dong-Sheng; Xu, Chun-Wei; Zheng, Min; Li, Ji-Sheng; Liu, Si-Yang; Yang, Ling-Ling; Jiang, Ben-Yuan; Ou, Qiu-Xiang; Qiu, Zhen-Bin; Shao, Yang; Wu, Yi-Long; Zhong, Wen-Zhao*npj Precision Oncology, 2022, 6(1): 66.被引 10
  • International expert consensus on immunotherapy for early-stage non-small cell lung cancer
    Liang, Wenhua; Cai, Kaican; Cao, Qingdong; Chen, Chun; Chen, Haiquan; Chen, Jun; Chen, Ke-Neng; Chen, Qixun; Chu, Tianqing; Dong, Yuchao; Fan, Jiang; Fang, Wentao; Fu, Junke; Fu, Xiangning; Gao, Shugeng; Ge, Di; Geng, Guojun; Geng, Qing; He, Jie; Hu, Jian; Hu, Jie; Hu, Wei-Dong; Jiang, Feng; Jiang, Tao; Jiao, Wenjie; Li, He-Cheng; Li, Qiang; Li, Shanqing; Li, Shuben; Li, Xiangnan; Liao, Yong-De; Liu, Changhong; Liu, Hongxu; Liu, Yang; Lu, Zhuming; Luo, Qingquan; Ma, Haitao; Pan, XiaojieTranslational Lung Cancer Research, 2022, 11(9): 1742-1762.被引 7
查看全部 →

发表信息

论文状态
公开发表
期刊
Cancer Communications
发表日期
2021-04
卷期
第 41 卷, 第 4 期
页码
287-302
DOI
10.1002/cac2.12153
期刊收录
NSL
期刊等级
1区
成果收录
SCIE

作者

  • K

    Kang, Jin (第一作者)

    guangdong prov peoples hosp

  • Z

    Zhang, Chao

    guangdong prov peoples hosp

查看全部 3 位作者收起作者
  • Z

    Zhong, Wen-Zhao (通讯)

    southern med univ · guangdong prov peoples hosp · 2

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417